The Bulletin
The Times


.

Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers

  • Written by The Bulletin
  • 87% of respondents deemed mRNA a key modality for the future
  • More than 60% vaccine makers surveyed plan revamp or new facilities for mRNA manufacturing to meet demand
  • Skilled personnel, tech-transfer expertise, reliable supply chain, and regulatory guidelines critical to new technology adoption

SINGAPORE - Media OutReach - 31 May 2023 - According to a recent study sponsored by Merck, a leading science and technology company, mRNA technology is a "game-changer" for Asia-Pacific (APAC) vaccine manufacturers.

Read more: Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers

hacklink hack forum hacklink film izle hacklink The Pokies casinoplay pokies onlineonline pokiesbest pokies sitesThe Pokies reviewalykellomiehelle.comThe Pokies bonusRoyal reelsAustralian pokiesreal money pokiesz-libGalabetplay Royal ReelsRoyal Reels pokiesRoyal Reels pokiesRoyal Reels loginBoss Rummycasinos not on gamstopnon gamstop casinos ukcasinos not on gamstopnon gamstop casinocasinos not on gamstoponline gamblingbest casinos not on gamstopgambling sites not on gamstopgambling sites not on gamstopPadişahbetcasibomRoyal reelsThe PokiesBetpipoBetpipoVipparkPadişahbetjojobetjojobet